Zinc Supplementation for Non-alcoholic Fatty Liver Disease: Literature Review

Trisha Anindya

doi:10.37899/journallamedihealtico.v6i6.2781

Trisha Anindya Medical Faculty, Universitas Udayana, Indonesia

DOI: https://doi.org/10.37899/journallamedihealtico.v6i6.2781

Keywords: Non-Alcoholic Fatty Liver, Disease (NAFLD), Zinc Supplementation, Adjuvant Therapy

Abstract

Non-Alcoholic Fatty Liver Disease (NAFLD) is closely associated with several metabolic factors, including dyslipidemia, insulin resistance, obesity, oxidative stress, and elevated inflammatory markers. NAFLD is also one of the most common liver diseases, in which zinc deficiency plays a key role in its pathogenesis. Zinc supplementation has been evaluated as a potential adjunctive therapy to improve clinical outcomes in patients with NAFLD. This literature review aims to discuss the possible role of zinc supplementation as an adjuvant therapy in patients with NAFLD, based on current research findings, and to contribute to the existing scientific literature.

References

Bañares, J., Aceituno, L., Ruiz-Ortega, L., Pons, M., Abraldes, J. G., & Genescà, J. (2024). Zinc Supplementation to Improve Prognosis in Patients with Compensated Advanced Chronic Liver Disease: a Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial. Hepatology Communications, 8(11). https://doi.org/10.1097/HC9.0000000000000524

Barbara, M., & Mindikoglu, A. L. (2021). The Role of Zinc in the Prevention and Treatment of Nonalcoholic Fatty Liver Disease. Metabolism Open, 11, 100105. https://doi.org/10.1016/j.metop.2021.100105

Bolatimi, O. E., Head, K. Z., Luo, J., Gripshover, T. C., Lin, Q., Adiele, N. V., Watson, W. H., Wilkerson, C., Cai, L., Cave, M. C., & Young, J. L. (2023). Can Zinc Supplementation Attenuate High Fat Diet-Induced Non-Alcoholic Fatty Liver Disease? International Journal of Molecular Sciences, 24(2), 1763. https://doi.org/10.3390/ijms24021763

Cao, B., Zhou, J., Xia, B., Li, X., Wang, R., Xu, Y., & Li, C. (2025). Therapeutic Potential of a Choline-Zinc-Vitamin E Nutraceutical Complex in Ameliorating Thioacetamide-Induced Nonalcoholic Fatty Liver Pathology in Zebrafish. PLOS One, 20(5), e0324164. https://doi.org/10.1371/journal.pone.0324164

Cao, X., Wang, N., Yang, M., & Zhang, C. (2025). Lipid accumulation and insulin resistance: Bridging metabolic dysfunction-associated fatty liver disease and chronic kidney disease. International journal of molecular sciences, 26(14), 6962. https://doi.org/10.3390/ijms26146962

Dubiński, P., Odzimek-Rajska, M., Podlewski, S., & Brola, W. (2025). Emerging Insights into the Role of the Microbiome in Brain Gliomas: A Systematic Review of Recent Evidence. International Journal of Molecular Sciences, 27(1), 444. https://doi.org/10.3390/ijms27010444

Fogacci, F., Giovannini, M., Di Micoli, V., Grandi, E., Borghi, C., & Cicero, A. F. G. (2024). Effect of Supplementation of a Butyrate-Based Formula in Individuals with Liver Steatosis and Metabolic Syndrome: A Randomized Double-Blind Placebo-Controlled Clinical Trial. Nutrients, 16(15), 2454. https://doi.org/10.3390/nu16152454

Fogacci, F., Rizzoli, E., Giovannini, M., Bove, M., D’Addato, S., Borghi, C., & Cicero, A. F. G. (2022). Effect of Dietary Supplementation with Eufortyn® Colesterolo Plus on Serum Lipids, Endothelial Reactivity, Indexes of Non-Alcoholic Fatty Liver Disease and Systemic Inflammation in Healthy Subjects with Polygenic Hypercholesterolemia: The ANEMONE Study. Nutrients, 14(10), 2099. https://doi.org/10.3390/nu14102099

Godoy-Matos, A. F., Silva Júnior, W. S., & Valerio, C. M. (2020). NAFLD as a continuum: from obesity to metabolic syndrome and diabetes. Diabetology & metabolic syndrome, 12(1), 60. https://doi.org/10.1186/s13098-020-00570-y

Himoto, T., & Masaki, T. (2018). Associations between Zinc Deficiency and Metabolic Abnormalities in Patients with Chronic Liver Disease. Nutrients, 10(1), 88. https://doi.org/10.3390/nu10010088

Hosui, A., Kimura, E., Abe, S., Tanimoto, T., Onishi, K., Kusumoto, Y., Sueyoshi, Y., Matsumoto, K., Hirao, M., Yamada, T., & Hiramatsu, N. (2018). Long-Term Zinc Supplementation Improves Liver Function and Decreases the Risk of Developing Hepatocellular Carcinoma. Nutrients, 10(12), 1955. https://doi.org/10.3390/nu10121955

Ito, T., Ishigami, M., Ishizu, Y., Kuzuya, T., Honda, T., Ishikawa, T., Toyoda, H., Kumada, T., & Fujishiro, M. (2020). Correlation of Serum Zinc Levels with Pathological and Laboratory Findings in Patients with Nonalcoholic Fatty Liver Disease. European Journal of Gastroenterology & Hepatology, 32(6), 748–753. https://doi.org/10.1097/MEG.0000000000001587

Jimenez Jimenez, A. M., Michalkova, H., Krizkova, S., Barreto de Melo Rego, M. J., Adam, V., & Merlos Rodrigo, M. A. (2025). New insights into the role of metallothioneins in obesity and diabetes: Molecular Biology. International Journal of Obesity, 49(10), 1958-1972. https://doi.org/10.1038/s41366-025-01850-1

Jomova, K., Alomar, S. Y., Valko, R., Nepovimova, E., Kuca, K., & Valko, M. (2025). The role of redox-active iron, copper, manganese, and redox-inactive zinc in toxicity, oxidative stress, and human diseases. EXCLI journal, 24, 880. https://doi.org/10.17179/excli2025-8449

Katayama, K. (2020). Zinc and Protein Metabolism in Chronic Liver Diseases. Nutrition Research, 74, 1–9. https://doi.org/10.1016/j.nutres.2019.11.009

Kim, M. C., Lee, J. I., Kim, J. H., Kim, H. J., Cho, Y. K., Jeon, W. K., Kim, B. I., & Sohn, W. (2020). Serum Zinc Level and Hepatic Fibrosis in Patients with Nonalcoholic Fatty Liver Disease. PLOS ONE, 15(10), e0240195. https://doi.org/10.1371/journal.pone.0240195

Liu, Y., Qin, X., Chen, T., Chen, M., Wu, L., & He, B. (2024). Exploring the Interactions between Metabolic Dysfunction-Associated Fatty Liver Disease and Micronutrients: from Molecular Mechanisms to Clinical Applications. Frontiers in Nutrition, 11. https://doi.org/10.3389/fnut.2024.1344924

Mayer, J. M., Botros, M., Grace, E., & Haddas, R. (2025). Functional Biomarkers Associated with Risk of Low Back Pain in Firefighters: A Systematic Review. Journal of Functional Morphology and Kinesiology, 10(4), 441. https://doi.org/10.3390/jfmk10040441

Nishikawa, H., Asai, A., & Fukunishi, S. (2022). The Significance of Zinc in Patients with Chronic Liver Disease. Nutrients, 14(22), 4855. https://doi.org/10.3390/nu14224855

Noshadi, N., Sabet, S. S., Sanaie, S., Mahmoodpoor, A., Tutunchi, H., Naghshi, S., ... & Ebrahimi-Mameghani, M. (2025). The effects of seven-strain probiotic supplementation on cell adhesion molecules, oxidative stress and antioxidant parameters in patients with traumatic brain injury: a randomised controlled clinical trial. British Journal of Nutrition, 133(7), 892-900. https://doi.org/10.1017/S0007114524003234

Palladini, G., Di Pasqua, L. G., Cagna, M., Croce, A. C., Perlini, S., Mannucci, B., Profumo, A., Ferrigno, A., & Vairetti, M. (2022). MCD Diet Rat Model Induces Alterations in Zinc and Iron during NAFLD Progression from Steatosis to Steatohepatitis. International Journal of Molecular Sciences, 23(12), 6817. https://doi.org/10.3390/ijms23126817

Qi, Y., Zhang, Z., Liu, S., Aluo, Z., Zhang, L., Yu, L., Li, Y., Song, Z., & Zhou, L. (2020). Zinc Supplementation Alleviates Lipid and Glucose Metabolic Disorders Induced by a High-Fat Diet. Journal of Agricultural and Food Chemistry, 68(18), 5189–5200. https://doi.org/10.1021/acs.jafc.0c01103

Reytor-González, C., Frias-Toral, E., Nuñez-Vásquez, C., Parise-Vasco, J. M., Zambrano-Villacres, R., Simancas-Racines, D., & Schiavo, L. (2025). Preventing and managing pre-and postoperative micronutrient deficiencies: a vital component of long-term success in bariatric surgery. Nutrients, 17(5), 741. https://doi.org/10.3390/nu17050741

Rezaei, S. M. A., Mohammadi, F., Eftekhari, M. H., Ejtehadi, F., Ghaem, H., & Mohammadipoor, N. (2023). The effects of zinc supplementation on the metabolic factors in patients with non-alcoholic fatty liver disease: a randomized, double-blinded, placebo-controlled clinical trial. BMC nutrition, 9(1), 138. https://doi.org/10.1186/s40795-023-00776-z

Rinaldi, L., Pafundi, P. C., Galiero, R., Caturano, A., Morone, M. V., Silvestri, C., ... & Sasso, F. C. (2021). Mechanisms of non-alcoholic fatty liver disease in the metabolic syndrome. A narrative review. Antioxidants, 10(2), 270. https://doi.org/10.3390/antiox10020270

Sadiq, I. Z., Usman, A., Muhammad, A., & Ahmad, K. H. (2025). Sample size calculation in biomedical, clinical and biological sciences research. Journal of Umm Al-Qura University for Applied Sciences, 11(1), 133-141. https://doi.org/10.1007/s43994-024-00153-x

Sangubotla, R., Syed, S., Mastan, A., Lakshmi, B. A., & Kim, J. (2025). Zinc-Mediated Defenses Against Toxic Heavy Metals and Metalloids: Mechanisms, Immunomodulation, and Therapeutic Relevance. International Journal of Molecular Sciences, 26(19), 9797. https://doi.org/10.3390/ijms26199797

Sheikh, M. Y., Younus, M. F., Shergill, A., & Hasan, M. N. (2025). Diet and lifestyle interventions in metabolic dysfunction-associated fatty liver disease: A comprehensive review. International Journal of Molecular Sciences, 26(19), 9625. https://doi.org/10.3390/ijms26199625

Soleimani, G., Conelea, C. A., Kuplicki, R., Opitz, A., Lim, K. O., Paulus, M. P., & Ekhtiari, H. (2025). Targeting VMPFC‐amygdala circuit with TMS in substance use disorder: A mechanistic framework. Addiction Biology, 30(1), e70011.

Tyczyńska, M., Hunek, G., Szczasny, M., Brachet, A., Januszewski, J., Forma, A., Portincasa, P., Flieger, J., & Baj, J. (2024). Supplementation of Micro- and Macronutrients—A Role of Nutritional Status in Non-Alcoholic Fatty Liver Disease. International Journal of Molecular Sciences, 25(9), 4916. https://doi.org/10.3390/ijms25094916

Varra, F. N., Theodosis-Nobelos, P., Varra, V. K., & Varras, M. (2025). Mechanistic Insights into Antioxidant Interventions Targeting Obesity-Induced Oxidative Stress in the Pathogenesis and Complications of Type 2 Diabetes Mellitus. Current Issues in Molecular Biology, 47(12), 1063. https://doi.org/10.3390/cimb47121063

Wei, C., Luo, Z., Hogstrand, C., Xu, Y., Wu, L., Chen, G., Pan, Y., & Song, Y. (2018). Zinc Reduces Hepatic Lipid Deposition and Activates Lipophagy Zn2+/MTF‐1/PPARα and Ca2+/CaMKKβ/AMPK Pathways. The FASEB Journal, 32(12), 6666–6680. https://doi.org/10.1096/fj.201800463

Xu, Y.-C., Zheng, H., Hogstrand, C., Tan, X.-Y., Zhao, T., Song, Y.-F., Wei, X.-L., Wu, L.-X., & Luo, Z. (2023). Novel Mechanism for Zinc Inducing Hepatic Lipolysis Via the HDAC3-Mediated Deacetylation of β-Catenin at Lysine 311. The Journal of Nutritional Biochemistry, 121, 109429. https://doi.org/10.1016/j.jnutbio.2023.109429

Yang, Z., Li, J., Zhang, J., & Sun, C. (2025). Magnesium Deficiency: The Insidious Executor of the Liver Disease. Journal of the American Nutrition Association, 44(5), 439-453. https://doi.org/10.1080/27697061.2024.2443063

Ye, M., He, Y., Xia, Y., Zhong, Z., Kong, X., Zhou, Y., ... & Li, Q. (2025). Association between serum zinc and non-alcoholic fatty liver disease and advanced liver fibrosis: NHANES 2011–2016. Biological Trace Element Research, 203(3), 1305-1316. https://doi.org/10.1007/s12011-024-04261-x